Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
Naka Shiratori,1,2 Yusuke Nishio,1,2 Ayaka Takeda,1,2 Shio Sugimoto,1,2 Kenji Takazawa,2 Naomi Otsuka,3 Naruhiro Ishida,3 Daisuke Shii,3 Kiyotaka Hori,3 Kenji Nakamoto1 1Department of Ophthalmology, Nippon Medical School, Tokyo, Japan; 2Shinanozaka Clinic, Tokyo, Japan; 3Japan Medical Affairs Group,...
Saved in:
Main Authors: | Shiratori N, Nishio Y, Takeda A, Sugimoto S, Takazawa K, Otsuka N, Ishida N, Shii D, Hori K, Nakamoto K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/73b6835fdbf44df590df1d2a07b4f63d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
by: Inoue K, et al.
Published: (2020) -
The 24-hour intraocular pressure control by tafluprost/timolol fixed combination after switching from the concomitant use of tafluprost and timolol gel-forming solution, in patients with primary open-angle glaucoma
by: Nakamoto K, et al.
Published: (2018) -
Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
by: Yosuke Ida, et al.
Published: (2021) -
The results of the toxicity and hazard studies of isopropyl meta-carborane with single administration to laboratory animals
by: G. G. Yushkov, et al.
Published: (2018) -
The results of a toxicological study of isopropyl meta-carborane with its multiple (chronic) intake into the body of laboratory animals
by: G. G. Yushkov, et al.
Published: (2018)